TauRx Pharmaceuticals - Clinical Research Society

Investigational Drug LMTX as a Glimmer of Hope for Alzheimer’s in Phase III Trials

LMTX, Tau, tau aggregation inhibitor, TauRx Pharmaceuticals

According to recently presented study at the Alzheimer’s Association International Conference 2016, researchers have completed the first recorded phase III

Offer the visitors your services or goods.

Describe what they will receive and how they will benefit from it.